BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 61 filers reported holding BURNING ROCK BIOTECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,280 | -77.2% | 319,876 | -49.5% | 0.00% | – |
| Q2 2023 | $1,362,511 | -37.3% | 633,726 | -18.1% | 0.00% | – |
| Q1 2023 | $2,173,945 | +5.9% | 773,646 | -15.2% | 0.00% | – |
| Q4 2022 | $2,052,025 | -6.2% | 912,011 | -0.3% | 0.00% | – |
| Q3 2022 | $2,187,000 | -22.8% | 914,993 | -6.1% | 0.00% | – |
| Q2 2022 | $2,834,000 | -65.6% | 974,196 | +10.0% | 0.00% | -100.0% |
| Q1 2022 | $8,230,000 | +64.6% | 885,812 | +68.8% | 0.00% | 0.0% |
| Q4 2021 | $5,000,000 | -40.2% | 524,718 | +12.2% | 0.00% | 0.0% |
| Q3 2021 | $8,361,000 | +80.7% | 467,641 | +197.9% | 0.00% | 0.0% |
| Q2 2021 | $4,626,000 | +14356.2% | 156,987 | +12960.5% | 0.00% | – |
| Q1 2021 | $32,000 | -81.6% | 1,202 | -84.1% | 0.00% | – |
| Q4 2020 | $174,000 | +93.3% | 7,539 | +109.1% | 0.00% | – |
| Q3 2020 | $90,000 | +309.1% | 3,605 | +343.4% | 0.00% | – |
| Q2 2020 | $22,000 | – | 813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |